Roger Song
Stock Analyst at Jefferies
(3.08)
# 2,584
Out of 4,534 analysts
256
Total ratings
42.1%
Success rate
2.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MANE Veradermics | Maintained: Buy | $182 | $106.04 | +71.63% | 5 | Jul 16, 2026 | |
| TGTX TG Therapeutics | Maintained: Buy | $83 | $53.96 | +53.82% | 6 | Jul 14, 2026 | |
| KRYS Krystal Biotech | Rated: Buy | $371 → $474 | $339.22 | +39.73% | 3 | Jul 13, 2026 | |
| UTHR United Therapeutics | Maintained: Buy | $733 → $714 | $529.34 | +34.88% | 16 | Jul 10, 2026 | |
| NRIX Nurix Therapeutics | Maintained: Buy | $45 | $22.71 | +98.15% | 6 | Jul 8, 2026 | |
| KLRA Kailera Therapeutics | Maintained: Buy | $48 | $17.91 | +168.01% | 3 | Jul 8, 2026 | |
| AVLN Avalyn Pharma | Initiated Coverage: Buy | $52 | $28.63 | +81.63% | 1 | May 26, 2026 | |
| SABS SAB Biotherapeutics | Initiated Coverage: Buy | $11 | $3.51 | +213.39% | 1 | May 20, 2026 | |
| FATE Fate Therapeutics | Initiated Coverage: Buy | $4 | $2.80 | +43.11% | 1 | May 19, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintained: Buy | $58 → $71 | $62.58 | +13.45% | 6 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.77 | +464.97% | 1 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $8 → $2 | $10.51 | -80.97% | 15 | Apr 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $18 | $5.73 | +214.14% | 4 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $22.32 | +177.78% | 6 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $2.75 | +409.09% | 3 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $16 | $3.52 | +354.55% | 5 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $91.71 | -50.93% | 3 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $46.98 | +166.07% | 17 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $36.38 | +177.63% | 11 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $42 | $14.10 | +197.87% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $154 | $74.38 | +107.04% | 6 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $121 | $64.84 | +86.61% | 11 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $10.68 | +162.17% | 20 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $5.88 | +172.11% | 1 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $40 | $22.59 | +77.07% | 3 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.31 | +281.68% | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $17 | $0.4864 | +3,395.07% | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $4 | $2.47 | +61.94% | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $60.14 | -40.14% | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.8 → $1.8 | $1.09 | +65.14% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $2.81 | n/a | 16 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $0.50 | n/a | 4 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $5.57 | n/a | 13 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 | $134.27 | n/a | 6 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $1.28 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $146 | $55.50 | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $18 | $1.74 | n/a | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $3.14 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.0031 | n/a | 4 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 | $30.70 | n/a | 2 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $25 | $7.88 | n/a | 16 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $1.5 | $3.79 | n/a | 6 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $3 | $15.05 | n/a | 5 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $68 | $35.42 | n/a | 2 | Nov 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $4.06 | n/a | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $124.15 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $2.93 | n/a | 1 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $10.00 | n/a | 1 | Apr 13, 2021 |
Veradermics
Jul 16, 2026
Maintained: Buy
Price Target: $182
Current: $106.04
Upside: +71.63%
TG Therapeutics
Jul 14, 2026
Maintained: Buy
Price Target: $83
Current: $53.96
Upside: +53.82%
Krystal Biotech
Jul 13, 2026
Rated: Buy
Price Target: $371 → $474
Current: $339.22
Upside: +39.73%
United Therapeutics
Jul 10, 2026
Maintained: Buy
Price Target: $733 → $714
Current: $529.34
Upside: +34.88%
Nurix Therapeutics
Jul 8, 2026
Maintained: Buy
Price Target: $45
Current: $22.71
Upside: +98.15%
Kailera Therapeutics
Jul 8, 2026
Maintained: Buy
Price Target: $48
Current: $17.91
Upside: +168.01%
Avalyn Pharma
May 26, 2026
Initiated Coverage: Buy
Price Target: $52
Current: $28.63
Upside: +81.63%
SAB Biotherapeutics
May 20, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $3.51
Upside: +213.39%
Fate Therapeutics
May 19, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $2.80
Upside: +43.11%
Kiniksa Pharmaceuticals International,
Apr 28, 2026
Maintained: Buy
Price Target: $58 → $71
Current: $62.58
Upside: +13.45%
Apr 15, 2026
Maintained: Buy
Price Target: $10
Current: $1.77
Upside: +464.97%
Apr 12, 2026
Downgraded: Hold
Price Target: $8 → $2
Current: $10.51
Upside: -80.97%
Mar 26, 2026
Rated: Buy
Price Target: $26 → $18
Current: $5.73
Upside: +214.14%
Mar 26, 2026
Maintained: Buy
Price Target: $62
Current: $22.32
Upside: +177.78%
Mar 23, 2026
Maintained: Buy
Price Target: $14
Current: $2.75
Upside: +409.09%
Mar 18, 2026
Reiterated: Buy
Price Target: $8 → $16
Current: $3.52
Upside: +354.55%
Mar 11, 2026
Maintained: Buy
Price Target: $45
Current: $91.71
Upside: -50.93%
Feb 27, 2026
Maintained: Buy
Price Target: $125
Current: $46.98
Upside: +166.07%
Feb 12, 2026
Maintained: Buy
Price Target: $101
Current: $36.38
Upside: +177.63%
Jan 22, 2026
Maintained: Buy
Price Target: $13 → $42
Current: $14.10
Upside: +197.87%
Dec 19, 2025
Maintained: Buy
Price Target: $154
Current: $74.38
Upside: +107.04%
Dec 17, 2025
Maintained: Buy
Price Target: $121
Current: $64.84
Upside: +86.61%
Dec 10, 2025
Maintained: Buy
Price Target: $28
Current: $10.68
Upside: +162.17%
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $16
Current: $5.88
Upside: +172.11%
Sep 9, 2025
Maintained: Buy
Price Target: $80 → $40
Current: $22.59
Upside: +77.07%
Aug 28, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.31
Upside: +281.68%
Aug 22, 2025
Maintained: Buy
Price Target: $9 → $17
Current: $0.4864
Upside: +3,395.07%
Aug 20, 2025
Maintained: Buy
Price Target: $12 → $4
Current: $2.47
Upside: +61.94%
Aug 15, 2025
Initiated Coverage: Buy
Price Target: $36
Current: $60.14
Upside: -40.14%
Aug 13, 2025
Maintained: Buy
Price Target: $4.8 → $1.8
Current: $1.09
Upside: +65.14%
Jun 26, 2025
Maintained: Buy
Price Target: $28
Current: $2.81
Upside: n/a
Jun 11, 2025
Maintained: Buy
Price Target: $10 → $8
Current: $0.50
Upside: n/a
Apr 24, 2025
Maintained: Buy
Price Target: $7
Current: $5.57
Upside: n/a
Apr 10, 2025
Maintained: Buy
Price Target: $68
Current: $134.27
Upside: n/a
Apr 1, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $1.28
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: $146
Current: $55.50
Upside: n/a
Mar 26, 2025
Rated: Buy
Price Target: $12 → $18
Current: $1.74
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: $7
Current: $3.14
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $8
Current: $0.0031
Upside: n/a
Jan 10, 2025
Rated: Buy
Price Target: $35
Current: $30.70
Upside: n/a
Oct 16, 2024
Maintained: Buy
Price Target: $31 → $25
Current: $7.88
Upside: n/a
Aug 21, 2024
Downgraded: Hold
Price Target: $14 → $1.5
Current: $3.79
Upside: n/a
Mar 27, 2024
Maintained: Buy
Price Target: $5 → $3
Current: $15.05
Upside: n/a
Nov 5, 2023
Rated: Buy
Price Target: $68
Current: $35.42
Upside: n/a
Jul 29, 2022
Initiated Coverage: Buy
Price Target: $9
Current: $4.06
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $6
Current: $124.15
Upside: n/a
Apr 29, 2021
Maintained: Buy
Price Target: $23
Current: $2.93
Upside: n/a
Apr 13, 2021
Initiated Coverage: Buy
Price Target: $29
Current: $10.00
Upside: n/a